REMEDi4ALL features in an article republished in The Age (Melbourne, Australia) on the power of AI in drug repurposing with an interview from REMEDi4ALL Scientific Coordinator Donald Lo.
Jeroen7 April 2025
The growing popularity of drug repurposing as a viable alternative to drug development to secure patient access to treatments has garnered media attention, with international news outlets reporting on repurposing initiatives including The REMEDi4ALL project. Below we have collated the most relevant articles where REMEDi4ALL has been mentioned by the press.
El País covers highlights the promise of Drug Repurposing and the REMEDi4ALL project (French translation).
Jeroen7 April 2025
El País covers highlights the promise of Drug Repurposing and the REMEDi4ALL project (Spanish version).
Jeroen7 April 2025
REMEDi4ALL features in a New York Times article on the power of AI in drug repurposing with an interview from REMEDi4ALL Scientific Coordinator Donald Lo.
Jeroen4 April 2025
REMEDi4ALL partner Beacon for Rare Diseases featured in Mediaplanet’s Rare Disease Day campaign – both online and in print.
In the piece, Beacon CEO Rick Thompson highlighted the power of multistakeholder collaborations like REMEDi4ALL, in accelerating the delivery of much-needed treatments to rare disease patients.
Jeroen4 April 2025
El País covers highlights the promise of Drug Repurposing and the REMEDi4ALL project (English version).
Jeroen4 April 2025
REMEDi4ALL Partners & Associated partners
